International Clinical Pharmacy Practice: Abstracts must describe the development, delivery, justification, or documentation of clinical pharmacy practice outside of the United States. Abstracts that describe efforts to develop, advance, or position clinical pharmacists to optimize patient care are encouraged. Abstracts may be descriptive and need not contain an evaluative component.
- Abstracts will be evaluated based on originality of the service or program, adequacy of justification/documentation, adaptability to other settings, and significance to international clinical pharmacy.
- Papers may be assigned to platform format based on the desire of the presenter and the recommendation of the reviewers.
- The abstract must not have been published in abstract form or presented elsewhere.
Abstract Deadline: February 15, 2015
International Clinical Pharmacy Education and Training: Abstracts must describe the development, delivery, or advancement of clinical pharmacy education/training outside of the United States. Abstracts may be descriptive and need not contain an evaluative component.
- Abstracts will be evaluated based on originality of the educational strategy or program, adequacy of justification/documentation, adaptability to other settings, and significance to international clinical pharmacy.
- Papers may be assigned to platform format based on the desire of the presenter and the recommendation of the reviewers.
- The abstract must not have been published in abstract form or presented elsewhere.
Abstract Deadline: February 15, 2015
Original Research: Abstracts must summarize hypothesis-driven research findings. Basic, clinical, translational, dissemination/implementation, or educational research are examples of acceptable research. Topics should appeal to a clinical pharmacy audience and may include: research in drug metabolism, education/pedagogy, health services, medication safety, patient/population outcomes, pharmacokinetics, pharmacodynamics, pharmacoeconomics, pharmacoepidemiology, pharmacogenomics, pharmacology, or pharmacotherapy. Abstracts reporting in vitro or animal research are welcome.
- Abstracts will be evaluated based on merits of hypotheses/objectives, study design, results, and conclusions.
- Descriptions of planned research efforts or preliminary data will not be accepted.
- To be eligible for Best Paper, Student Best Paper, or Resident/Fellow Best Paper the abstract must be submitted under this category.
- Papers may be assigned to platform format based on the desire of the presenter and the recommendation of the reviewers.
- A previously presented abstract may form the basis for a new abstract to be submitted for consideration in the Original Research category if the previous abstract:
- was a descriptive report of planned research only,
- described preliminary results only and complete results are now available,
- was presented at a student, resident, or fellow conference focused on gaining presentation experience and/or formative feedback,
- was presented at an ACCP Chapter or PRN event, or
- conclusions have been added/modified based on a new hypothesis and data analysis of the original results database.
** A copy of the original abstract and the full citation of where/when the research was presented must accompany submission. ACCP reserves the right to determine the extent of difference necessary to substantiate a new Original Research abstract submission.
Abstract Deadline: February 15, 2015
Clinical Pharmacy Forum: Abstracts must describe the development, delivery, justification, or documentation of innovative clinical pharmacy services. Abstracts that address components of the ACCP Standards of Practice for Clinical Pharmacists (see
http://www.accp.com/docs/positions/guidelines/standardsofpractice.pdf) and/or describe efforts to develop, advance, or position clinical pharmacists to optimize patient care are encouraged.
Abstracts may be descriptive and need not contain an evaluative component.
- Abstracts will be evaluated based on originality of the service or program, adequacy of justification/documentation, adaptability to other settings, and significance to clinical pharmacy.
- Papers may be assigned to platform format based on the desire of the presenter and the recommendation of the reviewers.
- The abstract must not have been published in abstract form or presented elsewhere.
Abstract Deadline: February 15, 2015
Residents and Fellows Research in Progress: Submission and evaluation criteria are those of an Original Research abstract except that the research effort is ongoing. Descriptions of planned research efforts without data should not be submitted. Submission of partially completed data is acceptable. Abstracts should provide an assessment of likelihood of project completion by date of presentation.
- The presenting author must be in a post-graduate training program (PGY-1 or PGY-2 residency, Ph.D./Masters graduate degree program, or fellowship program).
- Abstracts submitted in the Resident and Fellow Research in Progress category are not eligible for the Resident and Fellow Best Paper competition. *Note: to be eligible for the Resident and Fellow Best Paper competition, the research must be complete and the abstract submitted under the Original Research category, indicating that it was conducted by a resident/fellow.
International Trainee "Early Decision" Abstract Deadline: February 15, 2015
International Trainee "Late Decision" Abstract Deadline: July 1, 2015
U.S. Trainee Abstract Deadline: July 1, 2015
Students Research in Progress: Submission and evaluation criteria are those of an Original Research abstract except that the research effort is ongoing. Descriptions of planned research efforts without data should not be submitted. Submission of partially completed data is acceptable. Abstracts should provide an assessment of likelihood of project completion by date of presentation.
- The presenting author must be a first professional degree (Pharm.D. or B.S. Pharm.) student.
- All papers will be assigned to poster format.
- Abstracts submitted in the Student Research in Progress category are not eligible for the Student Best Paper competition. *Note: to be eligible for the Student Best Paper competition the research must be complete and the abstract submitted under the Original Research category, indicating that it was conducted by a student.
International Trainee "Early Decision" Abstract Deadline: February 15, 2015
International Trainee "Late Decision" Abstract Deadline: July 1, 2015
U.S. Trainee Abstract Deadline: July 1, 2015
Encore Presentation: Encore Presentation: Submission and evaluation criteria are those of either the Original Research or Clinical Pharmacy Forum category, except that the same abstract was presented elsewhere or published in abstract form only prior to this meeting.
- Abstracts submitted for Encore Presentations must not be modified from the previously presented/published version.
- The same abstract may not be presented at more than one national ACCP event.
- The full abstract will be published in the meeting program book only.
- Only the abstract title, authors, and original citation will be published in Pharmacotherapy.
- Encore Presentations will not be eligible for the Best Paper Award.
- Submit Encore Presentation abstracts as either Original Research or Clinical Pharmacy Forum and select "encore" when prompted, providing the original citation, and copy of original abstract.
Abstract Deadline: February 15, 2015
Guide to Writing an Abstract — Please read the guide to writing an abstract prior to submitting your abstract.